These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 24407917)

  • 21. Evaluation of the efficacy of an imidacloprid 10%/moxidectin 2.5% spot-on against Sarcoptes scabieivar canison dogs.
    Fourie LJ; Du Rand C; Heine J
    Parasitol Res; 2003 Jul; 90 Suppl 3():S135-6. PubMed ID: 12928880
    [No Abstract]   [Full Text] [Related]  

  • 22. Treatment of canine generalized demodicosis with a 'spot-on' formulation containing 10% moxidectin and 2.5% imidacloprid (Advocate, Bayer Healthcare).
    Mueller RS; Meyer D; Bensignor E; Sauter-Louis C
    Vet Dermatol; 2009 Oct; 20(5-6):441-6. PubMed ID: 20178482
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Non-Arsenical heartworm adulticidal therapy using topical moxidectin-imidacloprid and doxycycline: A prospective case series.
    Ames MK; VanVranken P; Evans C; Atkins CE
    Vet Parasitol; 2020 Jun; 282():109099. PubMed ID: 32450463
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microfilaricidal efficacy of a single administration of Advocate(®) (Bayer Animal Health) in dogs naturally infected with Dirofilaria immitis or Dirofilaria repens.
    Frangipane di Regalbono A; Di Cesare A; Traversa D; Simonato G; Poser H; Danesi P; Furnari C; Russi I; Raele DA; Crisi P; Pampurini F; Pietrobelli M
    Vet Parasitol; 2016 Aug; 226():30-4. PubMed ID: 27514879
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Imidacloprid/moxidectin topical solution for the prevention of heartworm disease and the treatment and control of flea and intestinal nematodes of cats.
    Arther RG; Charles S; Ciszewski DK; Davis WL; Settje TS
    Vet Parasitol; 2005 Oct; 133(2-3):219-25. PubMed ID: 16198823
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the efficacy and safety of imidacloprid 10% plus moxidectin 2.5% spot-on in the treatment of generalized demodicosis in dogs: results of a European field study.
    Heine J; Krieger K; Dumont P; Hellmann K
    Parasitol Res; 2005 Oct; 97 Suppl 1():S89-S96. PubMed ID: 16228281
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The anthelmintic efficacy and the safety of a combination of imidacloprid and moxidectin spot-on in cats and dogs under field conditions in Europe.
    Hellmann K; Knoppe T; Radeloff I; Heine J
    Parasitol Res; 2003 Jul; 90 Suppl 3():S142-3. PubMed ID: 12928883
    [No Abstract]   [Full Text] [Related]  

  • 28. Comparative evaluation of the prophylactic activity of a slow-release insecticide collar and a moxidectin spot-on formulation against Thelazia callipaeda infection in naturally exposed dogs in France.
    Lechat C; Siméon N; Pennant O; Desquilbet L; Chahory S; Le Sueur C; Guillot J
    Parasit Vectors; 2015 Feb; 8():93. PubMed ID: 25884443
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and duration of action of oral fluralaner and spot-on moxidectin/imidacloprid in cats infested with Lynxacarus radovskyi.
    Han HS; Noli C; Cena T
    Vet Dermatol; 2016 Dec; 27(6):474-e127. PubMed ID: 27870235
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An update on the therapy of canine demodicosis.
    Mueller RS
    Compend Contin Educ Vet; 2012 Apr; 34(4):E1-4. PubMed ID: 22488596
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of a spot-on imidacloprid-moxidectin formulation (Advocate®) for the treatment of naturally occurring esophageal spirocercosis in dogs: a double-blinded, placebo-controlled study.
    Segev G; Rojas A; Lavy E; Yaffe M; Aroch I; Baneth G
    Parasit Vectors; 2018 Mar; 11(1):127. PubMed ID: 29506575
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of a combination of imidacloprid 10%/moxidectin 2.5% spot-on (Advocate® for dogs) in the prevention of canine spirocercosis (Spirocerca lupi).
    Le Sueur C; Bour S; Schaper R
    Parasitol Res; 2010 Nov; 107(6):1463-9. PubMed ID: 20706736
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of the therapeutic and preventive efficacy of 2.5 % moxidectin / 10 % imidacloprid (Advocate(®), Bayer animal health) in dogs naturally infected or at risk of natural infection by Dirofilaria repens.
    Hellmann K; Heine J; Braun G; Paran-Dobesova R; Svobodova V
    Parasitol Res; 2011 Aug; 109 Suppl 1():S77-86. PubMed ID: 21739377
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of canine-generalized demodicosis: a blind, randomized clinical trial comparing the efficacy of Advocate(Bayer Animal Health) with ivermectin.
    Paterson TE; Halliwell RE; Fields PJ; Louw ML; Louw JP; Ball GS; Pinckney RD; McKibben JS
    Vet Dermatol; 2009 Oct; 20(5-6):447-55. PubMed ID: 20178483
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of imidacloprid 10%/moxidectin 2.5% spot on (Advocate®, Advantage Multi®) and doxycycline for the treatment of natural Dirofilaria immitis infections in dogs.
    Genchi M; Vismarra A; Lucchetti C; Viglietti A; Crosara S; Gnudi G; Quintavalla C; Schaper R; Kramer L
    Vet Parasitol; 2019 Sep; 273():11-16. PubMed ID: 31442887
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemical Compatibility and Safety of Imidacloprid/Flumethrin Collar (Seresto®) Concomitantly Used with Imidacloprid/Moxidectin (Advocate®, Advantage® Multi) and Emodepside/Praziquantel (Profender®) Spot-on Formulations.
    Krüdewagen EM; Remer C; Deuster K; Schunack B; Wolken S; Crafford D; Fourie J; Stanneck D
    Parasitol Res; 2015 Aug; 114 Suppl 1():S55-80. PubMed ID: 26152409
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of orally administered fluralaner (Bravecto™) or topically applied imidacloprid/moxidectin (Advocate®) against generalized demodicosis in dogs.
    Fourie JJ; Liebenberg JE; Horak IG; Taenzler J; Heckeroth AR; Frénais R
    Parasit Vectors; 2015 Mar; 8():187. PubMed ID: 25881320
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elimination of Dirofilaria (syn. Nochtiella) repens microfilariae in dogs with monthly treatments of moxidectin 2.5%/imidacloprid 10% (Advocate, Bayer) spot-on.
    Fok E; Jacsó O; Szebeni Z; Gyorffy A; Sükösd L; Lukács Z; Schaper R
    Parasitol Res; 2010 Apr; 106(5):1141-9. PubMed ID: 20165873
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dermatitis caused by autochthonous Cercopithifilaria bainae from a dog in Florida, USA: clinical, histological and parasitological diagnosis and treatment.
    Boyd M; Santoro D; Craft WF; Ginn PE; Childress AL; Wellehan JFX; Walden HS
    Vet Dermatol; 2019 Feb; 30(1):68-e20. PubMed ID: 30474318
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of a combination of 10% imidacloprid and 1% moxidectin against Caparinia tripilis in African pygmy hedgehog (Atelerix albiventris).
    Kim KR; Ahn KS; Oh DS; Shin SS
    Parasit Vectors; 2012 Aug; 5():158. PubMed ID: 22871121
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.